Loading...

Home
Stock
OGN

OGN News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

OGN News

Organon Receives FDA Approval for TOFIDENCE New Indications

4d agoNewsfilter

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

5d agoGlobenewswire

Investor Alert: Investigations into Multiple Mergers

5d agoGlobenewswire

Pharmaceutical Giants Accelerate Acquisitions to Offset Patent Cliffs

Jun 05 2026stocktwits

Organon to Present New Research Findings at ISPOR 2026

May 15 2026Newsfilter

Investor Rights Law Firm Investigates Multiple Companies

May 14 2026PRnewswire

Investigations into Multiple Company Acquisitions

May 14 2026Globenewswire

Investor Rights Law Firm Investigates Multiple Companies

May 07 2026Globenewswire

OGN Events

Q1 Revenue at $1.46B, Below Consensus of $1.49B

Reports Q1 revenue $1.46B, consensus $1.49B.

Organon Suspends Financial Guidance and Quarterly Earnings Calls

In light of the pending merger, Organon will not be providing financial guidance or hosting quarterly earnings calls.

OGN Monitor News

Sun Pharma to Acquire Organon for $14.00 per Share

Sun Pharma Competes to Acquire Organon with $13 Billion Bid

Organon faces acquisition interest amid market decline

Organon shares surge after Sun Pharma's $12B acquisition bid

Sun Pharma Submits $12B Bid for Organon, Shares Surge

Organon & Co. reaches 20-day high amid market gains

Organon Reports Disappointing Q4 Earnings, Shares Drop 13%

Organon Receives FDA Approval for NEXPLANON Extended Use

OGN Earnings Analysis

Organon & Co: Growth Strategies Amid Market Challenges- Intellectia AI™

People Also Watch